BRIEF-US FDA says it approves pfizer's ibrance (palbociclib) breast cancer drug

Feb 3 (Reuters) - Pfizer Inc : * US FDA says it approves pfizer's ibrance (palbociclib) breast cancer
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.